Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,195 | -6,807 | 2,484 | -1,234 | -2,860 |
| Depreciation Amortization | 4,246 | 1,801 | 5,659 | 3,795 | 3,024 |
| Accounts receivable | -745 | 6,055 | -19,744 | -11,780 | -7,964 |
| Accounts payable and accrued liabilities | -1,699 | 305 | 1,862 | 2,770 | 3,677 |
| Other Working Capital | -1,401 | 3,693 | -39,928 | -35,188 | -20,189 |
| Other Operating Activity | 10,802 | -2,189 | 37,436 | 23,213 | 13,392 |
| Operating Cash Flow | $8 | $2,858 | $-12,231 | $-18,424 | $-10,920 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -119,081 | -123,239 | -44,454 | 0 | 0 |
| PPE Investments | -1,818 | -505 | -9,748 | -3,218 | -2,108 |
| Net Acquisitions | -44,895 | -44,895 | N/A | N/A | N/A |
| Purchase Of Investment | -235 | -235 | -1,587 | -1,587 | -1,587 |
| Purchase Sale Intangibles | -55 | N/A | -120 | -40 | N/A |
| Other Investing Activity | -55 | 0 | -120 | -40 | 0 |
| Investing Cash Flow | $-166,084 | $-168,874 | $-55,909 | $-4,845 | $-3,695 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,983 | N/A | N/A |
| Debt Repayment | -287 | -146 | -50 | N/A | N/A |
| Common Stock Issued | 686 | 203 | 1,204 | 1,036 | 810 |
| Common Stock Repurchased | -15 | N/A | 1,585 | 765 | 765 |
| Other Financing Activity | -168 | -57 | -209 | -138 | -67 |
| Financing Cash Flow | $216 | $0 | $5,513 | $1,663 | $1,508 |
| Exchange Rate Effect | -2,096 | -1,090 | -2,491 | -1,489 | -1,617 |
| Beginning Cash Position | 299,500 | 299,500 | 364,618 | 364,618 | 364,618 |
| End Cash Position | 131,544 | 132,394 | 299,500 | 341,523 | 349,894 |
| Net Cash Flow | $-167,956 | $-167,106 | $-65,118 | $-23,095 | $-14,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8 | 2,858 | -12,231 | -18,424 | -10,920 |
| Capital Expenditure | -1,818 | -505 | -9,748 | -3,218 | -2,108 |
| Free Cash Flow | -1,810 | 2,353 | -21,979 | -21,642 | -13,028 |